| Mr Kartik Shatagopam, MD | |
|
401 Mocksville Ave Fl 2, Salisbury, NC 28144-2735 | |
| (704) 633-9620 | |
| (704) 633-7504 |
| Full Name | Mr Kartik Shatagopam |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 13 Years |
| Location | 401 Mocksville Ave Fl 2, Salisbury, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083905061 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Rowan Medical Center | Salisbury, NC | Hospital |
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Rowan Medical Center Llc | 3375452519 | 50 |
| Novant Medical Group Inc | 1153234893 | 1996 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306950282 PECOS PAC ID: 1153234893 Enrollment ID: O20040204001028 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | Novant Health Rowan Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508931544 PECOS PAC ID: 3375452519 Enrollment ID: O20040422001655 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | Novant Health Matthews Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | Novant Health Mint Hill Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063910404 PECOS PAC ID: 8123374394 Enrollment ID: O20181018000540 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Entity Name | Novant Health Ballantyne Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760190607 PECOS PAC ID: 4880065143 Enrollment ID: O20230518003163 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kartik Shatagopam, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 633-9620 | Mr Kartik Shatagopam, MD 401 Mocksville Ave Fl 2, Salisbury, NC 28144-2735 Ph: (704) 633-9620 |
News Archive
ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.
An innovative University of Liverpool research project that will investigate whether compounds used to treat snake venom and bee stings could provide an alternative to antibiotics in treating eye infection has been awarded £170,000 by the charity Fight for Sight.
An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.
› Verified 3 days ago
Dr. Khalid Altaf Mian, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1601 Brenner Ave, Salisbury, NC 28144 Phone: 704-638-9000 Fax: 704-638-3428 | |
Dr. Brent W Seifert, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Mocksville Ave, Salisbury, NC 28144 Phone: 704-633-7220 Fax: 704-647-0515 | |
Haritha Machavarapu, M.B.B.S Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 Mocksville Ave, Salisbury, NC 28144 Phone: 704-210-5260 Fax: 704-210-5265 | |
Dr. James E Bristol, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1601 Brenner Ave, Salisbury, NC 28144 Phone: 704-638-9000 | |
Dr. Nilesh V Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Mocksville Ave, Salisbury, NC 28144 Phone: 704-633-7220 Fax: 704-647-0515 | |
Dr. David J Bearss, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 Lincolnton Rd, Salisbury, NC 28144 Phone: 704-637-1123 Fax: 704-637-1214 | |
Mr. Hitesh P. Rabara, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1601 Brenner Ave, Va Medical Center, Salisbury, NC 28144 Phone: 704-638-9000 Fax: 704-638-3847 |